Octreotide (subcutaneous injection)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Octreotide (subcutaneous injection), covering 2024-08-26 to 2024-08-26. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) [Phase 2]